Further Information
Cyclin-dependent kinase 5 activator 1, CDK5 activator 1, Cyclin-dependent kinase 5 regulatory subunit 1, TPKII regulatory subunit, Cyclin-dependent kinase 5 activator 1, p35, p35, Cyclin-dependent kinase 5 activator 1, p25, p25, Tau protein kinase II 23 kDa subunit, p23, CDK5R1, CDK5R, NCK5A
For IHC-P starting dilution is: 1:10~50
For WB starting dilution is: 1:1000
p35 is a neuron-specific activator of cyclin-dependent kinase 5 (CDK5); the activation of CDK5 is required for proper development of the central nervous system. The p35 form of this protein is proteolytically cleaved by calpain, generating a p25 form. The cleavage of p35 into p25 results in relocalization of the protein from the cell periphery to nuclear and perinuclear regions. P25 deregulates CDK5 activity by prolonging its activation and changing its cellular location. The p25 form accumulates in the brain neurons of patients with Alzheimer's disease. This accumulation correlates with an increase in CDK5 kinase activity, and may lead to aberrantly phosphorylated forms of the microtubule-associated protein tau, which contributes to Alzheimer's disease.
- Lin,S., FEBS Lett. 582 (8), 1197-1202 (2008)
- Sen,A., Neuroreport 18 (5), 511-516 (2007)
- Mitsios,N., Brain Pathol. 17 (1), 11-23 (2007)
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Predicted species reactivity based on immunogen sequence: Bovine, Mouse, Rat
This CDK5R1(p35) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 272-301 amino acids from the C-terminal region of human CDK5R1(p35).
8851
Cyclin-dependent kinase 5 activator 1
CDK5R1
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
34 kDa
Q15078
2498217
This antibody is purified through a protein A column, followed by peptide affinity purification.
Cell Cycle,Neuroscience
Q15078
Optimal dilutions for each application to be determined by the researcher.